Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BerriHealth is a specialized biotechnology and nutraceutical company that focuses on the development and standardization of black raspberry-based products for clinical research and consumer health. The company is the primary provider of standardized, freeze-dried black raspberry powder and extracts used in numerous NIH-funded clinical trials investigating cancer prevention and treatment. Their products are specifically engineered to maintain high concentrations of bioactive phytochemicals, such as anthocyanins and ellagitannins, which have shown efficacy in reducing inflammation and inhibiting tumor growth in the gastrointestinal tract and oral cavity. By partnering with leading academic institutions, BerriHealth bridges the gap between nutritional science and clinical oncology. The company's offerings serve as a benchmark for quality in botanical drug and supplement research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BerriProducts.